These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36087938)

  • 1. Significant Rise in SARS-CoV-2 Reinfection Rate in Vaccinated Hospital Workers during the Omicron Wave: A Prospective Cohort Study.
    Ochoa-Hein E; Leal-Morán PE; Nava-Guzmán KA; Vargas-Fernández AT; Vargas-Fernández JF; Díaz-Rodríguez F; Rayas-Bernal JA; González-González R; Vázquez-González P; Huertas-Jiménez MA; Rajme-López S; Ramos-Cervantes P; Ibarra-González V; García-Andrade LA; Ledesma-Barrientos F; Ponce-de-León A; Sifuentes-Osornio J; Galindo-Fraga A
    Rev Invest Clin; 2022; 74(4):175-180. PubMed ID: 36087938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.
    Monteón V; León-Pérez F; Ancona-León JG; Gutiérrez-Torres G
    Salud Publica Mex; 2023 Dec; 66(1, ene-feb):14-16. PubMed ID: 38065105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
    Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
    Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model.
    Pople D; Monk EJM; Evans S; Foulkes S; Islam J; Wellington E; Atti A; Hope R; Robotham J; Hopkins S; Brown CS; Hall VJ;
    BMJ; 2022 Jul; 378():e070379. PubMed ID: 35858689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.
    Freire-Neto FP; Teixeira DG; da Cunha DCS; Morais IC; Tavares CPM; Gurgel GP; Medeiros SDN; Santos DCD; Sales AO; Jeronimo SMB
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010337. PubMed ID: 36191040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
    Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
    Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
    Jang EJ; Choe YJ; Yun GW; Wang S; Cho UJ; Yi S; Lee S; Park YJ
    J Med Virol; 2022 Nov; 94(11):5589-5592. PubMed ID: 35879105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Reinfection Cases in a Household-Based Prospective Cohort in Rio de Janeiro.
    Penetra SLS; Santos HFP; Resende PC; Bastos LS; da Silva MFB; Pina-Costa A; Lopes RS; Saboia-Vahia L; de Oliveira ACA; Pereira EC; Filho FM; Wakimoto MD; Calvet GA; Fuller TL; Whitworth J; Smith C; Nielsen-Saines K; Carvalho MS; Espíndola OM; Guaraldo L; Siqueira MM; Brasil P
    J Infect Dis; 2023 Dec; 228(12):1680-1689. PubMed ID: 37571849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis.
    Flacco ME; Acuti Martellucci C; Baccolini V; De Vito C; Renzi E; Villari P; Manzoli L
    Eur J Clin Invest; 2022 Oct; 52(10):e13845. PubMed ID: 35904405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant.
    Shete AM; Patil DY; Sahay RR; Sapkal GN; Deshpande GR; Yadav PD
    Hum Vaccin Immunother; 2022 Nov; 18(6):2127289. PubMed ID: 36170667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Immunological Evasion of the Delta (B.1.617.2) and Omicron (B.1.1.529) SARS-CoV-2 Variants: A Retrospective Study on the Veneto Region's Population.
    Cocchio S; Zabeo F; Facchin G; Piva N; Venturato G; Marcon T; Saia M; Tonon M; Mongillo M; Da Re F; Russo F; Baldo V
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent symptomatic Omicron infection reduced COVID-19 pneumonia risk during reinfection: A computed tomography-based cohort study.
    Zheng Y; Jia S; Tang L; Yu L; Yang X; Yang S; Ke Q; Cheng Z; Zhu Y; Chen H; Hong P
    Int J Infect Dis; 2024 Sep; 146():107164. PubMed ID: 38969328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study.
    Ma X; Wang Z; Chen Y; Li Z
    BMC Infect Dis; 2024 Mar; 24(1):354. PubMed ID: 38539124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris.
    Wack M; Péré H; Demory-Guinet N; Kassis-Chikhani N; Janot L; Vedie B; Izquierdo L; Bélec L; Veyer D
    J Clin Virol; 2021 Dec; 145():104999. PubMed ID: 34695725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis.
    Zou Y; Huang D; Jiang Q; Guo Y; Chen C
    Front Public Health; 2022; 10():940956. PubMed ID: 35910897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study.
    Flacco ME; Soldato G; Acuti Martellucci C; Di Martino G; Carota R; Caponetti A; Manzoli L
    Front Public Health; 2022; 10():884121. PubMed ID: 35586006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.